Verona Pharma plc buy HC Wainwright
Start price
21.01.25
/
50%
€0.51
Target price
21.01.26
€57.80
Performance (%)
-
End price
22.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by HC_Wainwright for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock, up previously from $42.00.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten